Scott Boyle, Ph.D. joined C4 Therapeutics in January 2022 as our Chief Business Officer. Previously, Scott was at Forma Therapeutics as Vice President, Business and Corporate Development. He has served clients in oncology and precision medicine at Boston Consulting Group (BCG) and built the business development function at Caris Life Sciences, where he held roles of increasing responsibility. Scott earned a Bachelor of Science degree in biochemistry from Brigham Young University, a Ph.D. in molecular biophysics and biochemistry from Yale University and an MBA from the Harvard Business School. He completed his postdoctoral fellowship at the Novartis Institute for Biomedical Research.